Caitong International Asset Management Co., LTD Recursion Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 264 shares of RXRX stock, worth $2,779. This represents 0.0% of its overall portfolio holdings.
Number of Shares
264
Previous 264
-0.0%
Holding current value
$2,779
Previous $1.79 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
337Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$358 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$341 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$262 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$182 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$154 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.9B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...